TITLE 77: PUBLIC HEALTH
CHAPTER I: DEPARTMENT OF PUBLIC HEALTH
SUBCHAPTER k: COMMUNICABLE DISEASE CONTROL AND IMMUNIZATIONS
PART 690 CONTROL OF COMMUNICABLE DISEASES CODE
SECTION 690.620 RUBELLA (GERMAN MEASLES) (INCLUDING CONGENITAL RUBELLA SYNDROME) (REPORTABLE BY TELEPHONE, FACSIMILE OR ELECTRONICALLY AS SOON AS POSSIBLE, WITHIN 24 HOURS)


 

Section 690.620  Rubella (German Measles) (Including Congenital Rubella Syndrome) (Reportable by telephone, facsimile or electronically as soon as possible, within 24 hours)

 

a)         Control of Case

 

1)         Standard precautions shall be followed.  Droplet precautions shall be followed for persons in health care facilities for seven days after onset of the rash.

 

2)         Infants with congenital rubella syndrome may shed virus for months.

Contact precautions shall be followed for infants less than 12 months of age with congenital rubella syndrome in a health care facility, unless urine and pharyngeal virus cultures are negative for rubella virus after three months of age.

 

3)         Rubella cases should be isolated from pregnant females.  If a pregnant woman is exposed, a blood specimen should be obtained and tested for rubella IgG specific and IgM specific antibodies.

 

4)         Cases shall be excluded from school, child care facilities or the workplace for seven days after onset of the rash.

 

b)         Control of Contacts

 

1)         Susceptible contacts should be excluded from school or the workplace from days seven through 23 following rash onset after last exposure.

 

2)         Susceptible health care workers exposed to rubella should receive a dose of MMR vaccine and should be excluded from duty after the seventh day after first exposure through the 23rd day after last exposure or until seven days after the rash appears.  Susceptible exposed health care workers who are vaccinated should be excluded from direct patient care for 23 days after the last exposure to rubella, as no evidence exists that post-exposure vaccination is effective in preventing rubella infection in persons already infected at the time of vaccination.

 

c)         Laboratory Reporting

Laboratories shall report to the local health authority patients who have a positive result on any laboratory test indicative of and specific for detecting rubella virus infection, including positive results from IgM (rubella specific) serology, rubella virus isolates, or a significant rise in antibody results from IgG (rubella specific) from paired serologies.

 

(Source:  Amended at 38 Ill. Reg. 5533, effective February 11, 2014)